Food and drug supplements to improve fertility outcomes

Seminars in Reproductive Medicine

Volumn 32, Issue 4, 2014, Pages 245-252

  Urman, Bulent ^a,b   Oktem, Ozgur ^a,b  

^a AMERICAN HOSPITAL   (Turkey)

^b KOÇ UNIVERSITY   (Turkey)

Author keywords

alternative medicine; antioxidants; drug supplements; fertility; food supplements; infertility

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINO ACID; ANTIINFECTIVE AGENT; ARGININE; ASCORBIC ACID; BETA CAROTENE; CALCIUM; CLOMIFENE; COPPER ZINC SUPEROXIDE DISMUTASE; FOLLITROPIN RECEPTOR; FREE RADICAL; GONADOTROPIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INOSITOL; MELATONIN; NUCLEIC ACID; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; POLYCYCLIC AROMATIC HYDROCARBON; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; REACTIVE OXYGEN METABOLITE; SELENIUM; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VITAMIN D; ZINC; ANTIOXIDANT; FERTILITY PROMOTING AGENT;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; ATHEROSCLEROSIS; CHINESE MEDICINE; DIET SUPPLEMENTATION; DNA POLYMORPHISM; ECTOPIC PREGNANCY; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPERANDROGENISM; HYPERTENSION; INFERTILITY THERAPY; INSULIN RESISTANCE; INTRACYTOPLASMIC SPERM INJECTION; LIPID PEROXIDATION; LIVE BIRTH; MALE INFERTILITY; MULTIPLE PREGNANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PHOSPHATE METABOLISM; PREGNANCY RATE; RISK FACTOR; SECONDARY AMENORRHEA; SEMINAL PLASMA; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SPONTANEOUS ABORTION; THERAPY EFFECT; TREATMENT OUTCOME; VITEX AGNUS CASTUS; ANIMAL; DRUG EFFECTS; FEMALE; FERTILITY; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; PATHOPHYSIOLOGY; PREGNANCY;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; FEMALE; FERTILITY; FERTILITY AGENTS; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT OUTCOME;

EID: 84902386260     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1375176     Document Type: Article

References (54)

1. Dennehy C. E. The use of herbs and dietary supplements in gynecology: an evidence-based review. J Midwifery Womens Health: 2006; 51 6 402 409 (Pubitemid 44615959)
2. Eisenberg D. M., Davis R. B., Ettner S. L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA: 1998; 280 18 1569 1575 (Pubitemid 28520643)
3. Zoorob R. J., Sidani M., Williams J., Grief S. N. Women's health: selected topics. Prim Care: 2010; 37 2 367 387
4. Foresta C., Bettella A., Garolla A., Ambrosini G., Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril: 2005; 84 3 654 661 (Pubitemid 41317724)
5. Selice R., Garolla A., Pengo M., Caretta N., Ferlin A., Foresta C. The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl: 2011; 34 4 306 312
6. Vandekerckhove P., Lilford R., Vail A., Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev: 2000; 2 CD000151
7. Raman J. D., Schlegel P. N. Aromatase inhibitors for male infertility. J Urol: 2002; 167 2, Pt 1 624 629 (Pubitemid 34074542)
8. Vandekerckhove P., Lilford R., Vail A., Hughes E. Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev: 2000; 2 CD000150
9. Ross C., Morriss A., Khairy M., et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online: 2010; 20 6 711 723
10. Tremellen K., Miari G., Froiland D., Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol: 2007; 47 3 216 221 (Pubitemid 46909301)
11. Zini A., Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian J Androl: 2011; 13 3 374 381
12. Ramasamy R., Stahl P. J., Schlegel P. N. Medical therapy for spermatogenic failure. Asian J Androl: 2012; 14 1 57 60
13. Zini A., San Gabriel M., Baazeem A. Antioxidants and sperm DNA damage: a clinical perspective. J Assist Reprod Genet: 2009; 26 8 427 432
14. Comhaire F., Decleer W. Quantifying the effectiveness and cost-efficiency of food supplementation with antioxidants for male infertility. Reprod Biomed Online: 2011; 23 3 361 362
15. Allison J. L., Schust D. J. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes: 2009; 16 6 446 450
16. Gil-Villa A. M., Cardona-Maya W., Agarwal A., Sharma R., Cadavid A. Role of male factor in early recurrent embryo loss: do antioxidants have any effect? Fertil Steril: 2009; 92 2 565 571
17. Agarwal A., Gupta S., Sharma R. K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol: 2005; 3 28
18. Lloyd K. B., Hornsby L. B. Complementary and alternative medications for women's health issues. Nutr Clin Pract: 2009; 24 5 589 608
19. Suzuki T., Sugino N., Fukaya T., et al. Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril: 1999; 72 4 720 726 (Pubitemid 29475137)
20. Jones D. P. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol: 2008; 295 4 C849 C868
21. Shkolnik K., Tadmor A., Ben-Dor S., Nevo N., Galiani D., Dekel N. Reactive oxygen species are indispensable in ovulation. Proc Natl Acad Sci U S A: 2011; 108 4 1462 1467
22. Park J. I., Jeon H. J., Jung N. K., et al. Periovulatory expression of hydrogen peroxide-induced sulfiredoxin and peroxiredoxin 2 in the rat ovary: gonadotropin regulation and potential modification. Endocrinology: 2012; 153 11 5512 5521
23. Oyawoye O. A., Abdel-Gadir A., Garner A., Leonard A. J., Perrett C., Hardiman P. The interaction between follicular fluid total antioxidant capacity, infertility and early reproductive outcomes during in vitro fertilization. Redox Rep: 2009; 14 5 205 213
24. Henmi H., Endo T., Kitajima Y., Manase K., Hata H., Kudo R. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril: 2003; 80 2 459 461 (Pubitemid 36959812)
25. Prieto L., Quesada J. F., Cambero O., et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril: 2012; 98 1 126 130
26. Singh A. K., Chattopadhyay R., Chakravarty B., Chaudhury K. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol: 2013; 42 116 124
27. Mier-Cabrera J., Aburto-Soto T., Burrola-Méndez S., et al. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol: 2009; 7 54
28. Griesinger G., Franke K., Kinast C., et al. Ascorbic acid supplement during luteal phase in IVF. J Assist Reprod Genet: 2002; 19 4 164 168 (Pubitemid 34522446)
29. Paszkowski T., Traub A. I., Robinson S. Y., McMaster D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta: 1995; 236 2 173 180
30. Özkaya M. O., Nazıroǧlu M., Barak C., Berkkanoglu M. Effects of multivitamin/mineral supplementation on trace element levels in serum and follicular fluid of women undergoing in vitro fertilization (IVF). Biol Trace Elem Res: 2011; 139 1 1 9
31. Edassery S. L., Shatavi S. V., Kunkel J. P., et al. Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril: 2010; 94 7 2636 2641
32. Seko L. M., Moroni R. M., Leitao V. M., et al. Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials. Fertil Steril: 2014; 101 1 154, e4
33. Bergmann J., Luft B., Boehmann S., Runnebaum B., Gerhard I. [The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study]. Forsch Komplementarmed Klass Naturheilkd: 2000; 7 4 190 199
34. Roemheld-Hamm B. Chasteberry. Am Fam Physician: 2005; 72 5 821 824 (Pubitemid 41254252)
35. Westphal L. M., Polan M. L., Trant A. S., Mooney S. B. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med: 2004; 49 4 289 293 (Pubitemid 38525190)
36. Westphal L. M., Polan M. L., Trant A. S. Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in women. Clin Exp Obstet Gynecol: 2006; 33 4 205 208 (Pubitemid 44912931)
37. Showell M. G., Brown J., Clarke J., Hart R. J. Antioxidants for female subfertility. Cochrane Database Syst Rev: 2013; 8 CD007807
38. Luk J., Torrealday S., Neal Perry G., Pal L. Relevance of vitamin D in reproduction. Hum Reprod: 2012; 27 10 3015 3027
39. Ott J., Wattar L., Kurz C., et al. Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study. Eur J Endocrinol: 2012; 166 5 897 902
40. Ozkan S., Jindal S., Greenseid K., et al. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril: 2010; 94 4 1314 1319
41. Aleyasin A., Aghahoseini M., Mokhtar S., Fallahi P. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients. Acta Med Iran: 2011; 49 11 715 720
42. Anifandis G. M., Dafopoulos K., Messini C. I., et al. Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in the IVF outcome. Reprod Biol Endocrinol: 2010; 8 91
43. Ried K., Stuart K. Efficacy of traditional Chinese herbal medicine in the management of female infertility: a systematic review. Complement Ther Med: 2011; 19 6 319 331
44. Gleicher N., Barad D. H. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol: 2011; 9 67
45. Urman B., Yakin K. DHEA for poor responders: can treatment be justified in the absence of evidence? Reprod Biomed Online: 2012; 25 2 103 107
46. Urman B., Yakin K. Does dehydroepiandrosterone have any benefit in fertility treatment? Curr Opin Obstet Gynecol: 2012; 24 3 132 135
47. Yakin K., Urman B. DHEA as a miracle drug in the treatment of poor responders; hype or hope? Hum Reprod: 2011; 26 8 1941 1944
48. Thompson R. D., Carlson M., Thompson R. D., Carlson M. Liquid chromatographic determination of dehydroepiandrosterone (DHEA) in dietary supplement products. J AOAC Int: 2000; 83 4 847 857
49. Barad D. H., Weghofer A., Gleicher N. Dehydroepiandrosterone treatment of ovarian failure. Fertil Steril: 2009; 91 5 e14, author reply e15
50. Gleicher N., Weghofer A., Barad D. H. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online: 2010; 21 3 360 365
51. Wiser A., Gonen O., Ghetler Y., Shavit T., Berkovitz A., Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod: 2010; 25 10 2496 2500
52. Kolibianakis E. M., Venetis C. A., Tarlatzis B. C. DHEA administration in poor responders. Hum Reprod: 2011; 26 3 730 731, author reply 731
53. Kara M., Aydin T., Aran T., et al. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? Eur J Obstet Gynecol Reprod Biol: 2014; 173 63 65
54. Raja-Khan N., Stener-Victorin E., Wu X., Legro R. S. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab: 2011; 301 1 E1 E10